Association of the atherosclerosis, small vessel disease, cardioembolism, other causes with the executive function of the montreal cognitive assessment Indonesia in patients with post ischemic stroke
Keywords:ASCO, Executive function, MoCA INA, Post ischemic stroke
Background: ASCO Phenotype classification is a new classification of stroke based on phenotypic system. ASCO classification can evaluate the etiology of ischemic stroke comprehensively to characterize patients using different grade of evidence for the subtype of ischemic stroke. ASCO classification can predict post ischemic stroke cognitive decline. This Study purpose to evaluate the association between ASCO classification with the executive function in post ischemic stroke patients.
Methods: This cross sectional study followed by 28 post ischemic stroke patients (men 16, women 12) over 3 months. Mean age 52.82±8.66. Cognitive function was assessed by Montreal Cognitive Assessment Indonesia (MoCA INA).
Results: There were 17 patients with grade 1 atherosclerosis (ASCO A1), ten patients with grade 1 small vessel disease (ASCO S1), one patient with grade 1 cardioembolism (ASCO C1) in post ischemic stroke. Grade 1 atherosclerosis (ASCO A1) was significantly associated with executive function decline (p=0.002), naming decline (p=0.05), abstraction decline (p=0.001), memory decline (p=0.002) and orientation decline (p=0.016)). Grade 1 small vessel disease (ASCO S1) was significantly associated with executive function decline (p=0.001) and memory decline (p = 0.001) and abstraction (p=0.001). Grade 1 cardioembolism 1 (ASCO C1) was not significantly associated with cognitive decline.
Conclusions: There was significant association between ASCO classification with the executive function of Montreal Cognitive Assestment Indonesia (MoCA INA) in post ischemic stroke patients.
Mellon L, Brewer L, Hall P, Horgan, Williams D, Hickey A, et al. Cognitive impairment six months after ischemic stroke: a profile from the ASPIRE-S study. BMC Neurology. 2015;15:31.
Radu RA, dan Terecoasa EO. Clinical Neurology and Neurosurgery. Elsevier. 2017;159:93-106.
Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke. Cerebrovascular Diseases. 2009;27:502-8
Kim JB, Kim SJ. Ischemic stroke subtype classification: an Asian viewpoint. J Stroke. 2014;16(1):8-17.
Sun HJ, Tan L, and Yu TJ. Post stroke cognitive impairment: epidemiology, mechanism and management. Ann Trans. Med. 2014;2(8):80.
Douri A, Rudd AG, Wolfe ADC. Prevalence of post stroke cognitive impairment. Stroke. 2013;44:138-45.
Tuladhar AM, Norden AG, Laat AF, Zwiers MP, Dijk E, Norris D, et al. White matter integrity in small vessel disease is related to cognition. Neuroimage. 2015;7:518-24.
Shah DA, Merchant MF, Delurgio BD. Atrial fibrillation and risk of dementia/cognitive decline. Journal of Atrial Fibrillation. 2016;8(5):53-60.
Romero RJ, Beiser A, Seshadri S, benjamin E, Polak FJ, Vasar SR, et al. Carotid artery atherosclerosis, mri indices of brain ischemia, aging, and cognitive impairment. Stroke. 2009;40:1590-6.
Love SA, Palta P, Kalbaugh C, Sharret A, Gross AL, Alonso A, et al. Subclinical atherosclerosis and 20-year cognitive decline: The Atherosclerosis Risk in Communities (ARIC). Neurocognitive study. Circulation. 2015;131:A47.
Carey LC, Kramer HJ, Josepshon Mungas D, Reed RB, Schuff N, et al. Subcortical Lacunes are associated with executive. Stroke. 2008;39:397- 402.
Washida K, Ihara M, Tachibana H, Sekiguchi K, Kowa H, Kanda F, et al. Association of the ASCO classification with the executive function subscores of the montreal cognitive assessment in patients with post-ischemic stroke. J Stroke Cerebrovascular Dis. 2014;23(1):2250-5.
Lawrence JA, Patel B, Morris GR, Mackinnan DA, Rich MP, Barrick RT. Mechanism of cognitive impairment in cerebral small vessel disease: Multimodal MRI result from the St. George Cognitive and Neuroimaging in Stroke (SCANS) study. Plos One J. 2013;8(4):1-5.